SANDOZ DICLOFENAC RAPIDE 50 MG — DIN 02261774
DICLOFENAC POTASSIUM : 50 MG · SANDOZ CANADA INCORPORATED · TABLET · wholesale supply in Canada
Health Canada status: MARKETED
What is SANDOZ DICLOFENAC RAPIDE?
SANDOZ DICLOFENAC RAPIDE 50 MG contains DICLOFENAC POTASSIUM : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 02261774, held by SANDOZ CANADA INCORPORATED, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 02-Feb-2006. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is SANDOZ DICLOFENAC RAPIDE used for?
Sandoz Diclofenac Rapide (diclofenac potassium) is indicated for the short - term (up to one week) treatment of acute, mild to moderately severe pain that may be accompanied by inflammation, in conditions such as: musculoskeletal and/or soft tissue trauma including sprains, post - operative pain following dental extraction, episiotomy, or dysmenorrhea.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Diclofenac cost around the world?
Diclofenac is listed on 10 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Belgium publishes a public; Greece publishes a producer price (ex-factory). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Morocco | PPV (public price) | 26 | 74 | MAD███.██ |
| United States | acquisition | 6 | 41 | USD███.██ |
| Italy | prezzo al pubblico (classe A) | 28 | 40 | EUR███.██ |
| South Africa | single exit price | 25 | 35 | ZAR███.██ |
| Australia | ex-manufacturer | 9 | 22 | AUD███.██ |
| Romania | max producer price | 15 | 21 | RON███.██ |
| Greece | producer price (ex-factory) | 13 | 13 | EUR███.██ |
| United Kingdom | hospital | 10 | 10 | GBP███.██ |
| Hungary | producer price (ex-factory) | 2 | 3 | HUF███.██ |
| Belgium | public | 1 | 1 | EUR███.██ |
260 pack listings across 135 brand entries and 9 price bases, refreshed 08 Sep 2026. Ranges span every Diclofenac pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Diclofenac in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
16 holders have a Canadian DIN containing Diclofenac, across 74 DINs, of which 15 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| APOTEX INC | 5 | 4 | APO-DICLO, APO-DICLO RAPIDE 50 MG TABLETS, APO-DICLO SR | Sourceable in Canada |
| TEVA CANADA LIMITED | 10 | 3 | NTP-DICLOFENAC POTASSIUM, NTP-DICLOFENAC SODIUM, NTP-DICLOFENAC SODIUM SR, TEVA-DICLOFENAC, TEVA-DICLOFENAC EC, +2 more | Sourceable in Canada |
| PHARMASCIENCE INC | 9 | 2 | PMS-DICLOFENAC, PMS-DICLOFENAC K, PMS-DICLOFENAC-SR | Sourceable in Canada |
| SANDOZ CANADA INCORPORATED | 9 | 2 | SANDOZ DICLOFENAC, SANDOZ DICLOFENAC RAPIDE, SANDOZ-DICLOFENAC, SANDOZ-DICLOFENAC SR | Sourceable in Canada |
| NOVARTIS PHARMACEUTICALS CANADA INC | 7 | 2 | VOLTAREN, VOLTAREN RAPIDE, VOLTAREN SR, VOLTAREN TAB 25MG | Sourceable in Canada |
| PRO DOC LIMITEE | 5 | 1 | DICLOFENAC ECT 25MG, DICLOFENAC-SR, PRO-DICLO RAPIDE - 50, PRO-DICLOFENAC | Sourceable in Canada |
| ARALEZ PHARMACEUTICALS CANADA INC | 1 | 1 | CAMBIA | Sourceable in Canada |
| NU-PHARM INC | 5 | 0 | NU-DICLO ENTERIC COATED TAB 25MG, NU-DICLO ENTERIC COATED TAB 50MG, NU-DICLO RAPIDE, NU-DICLO SR - SRT 100MG, NU-DICLO SR - SRT 75MG | No marketed DIN |
| AVANSTRA INC | 4 | 0 | AVA-DICLOFENAC, AVA-DICLOFENAC SR | No marketed DIN |
| DOMINION PHARMACAL | 4 | 0 | DOM-DICLOFENAC, DOM-DICLOFENAC-SR | No marketed DIN |
| LABORATOIRE RIVA INC. | 4 | 0 | RIVA-DICLOFENAC 100MG SR TABLETS, RIVA-DICLOFENAC 50MG TABLETS, RIVA-DICLOFENAC 75MG SR TABLETS, RIVA-DICLOFENAC-K 50MG TABLETS | No marketed DIN |
| SANIS HEALTH INC | 3 | 0 | DICLOFENAC EC, DICLOFENAC K, DICLOFENAC SR | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 50 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
| Pack configuration (monograph) | null |
| Storage | null |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Diclofenac |
|---|---|
| ATC code | M01AB05 |
| AHFS class | 24:24.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02261774 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2261774 |
| Brand name | SANDOZ DICLOFENAC RAPIDE |
| Generic / active ingredient | DICLOFENAC POTASSIUM : 50 MG |
| Market authorization holder | SANDOZ CANADA INCORPORATED |
| Health Canada schedule | Prescription |
| ATC code | M01AB05 |
| ATC anatomical main group | M — Musculo-skeletal system |
| ATC therapeutic subgroup | M01AB |
| Current status | MARKETED |
| Status date | 02-Feb-2006 |
| Original market date | 2006-04-07 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
Is Diclofenac in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by PHARMA STULLN INC., last seen 09 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
15 of 74 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-DICLO | 50 MG | TABLET (ENTERIC-COATED) | APOTEX INC | MARKETED | 00839183 |
| APO-DICLO | 25 MG | TABLET (ENTERIC-COATED) | APOTEX INC | MARKETED | 00839175 |
| APO-DICLO SR | 100 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED | 02091194 |
| APO-DICLO SR | 75 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED | 02162814 |
| CAMBIA | 50 MG | POWDER FOR SOLUTION | ARALEZ PHARMACEUTICALS CANADA INC | MARKETED | 02381680 |
| PMS-DICLOFENAC | 25 MG | TABLET (DELAYED-RELEASE) | PHARMASCIENCE INC | MARKETED | 02302616 |
| PMS-DICLOFENAC | 50 MG | TABLET (DELAYED-RELEASE) | PHARMASCIENCE INC | MARKETED | 02302624 |
| PRO-DICLOFENAC | 50 MG | TABLET (DELAYED-RELEASE) | PRO DOC LIMITEE | MARKETED | 00870978 |
| SANDOZ-DICLOFENAC | 50 MG | SUPPOSITORY | SANDOZ CANADA INCORPORATED | MARKETED | 02261928 |
| TEVA-DICLOFENAC EC | 50 MG | TABLET (ENTERIC-COATED) | TEVA CANADA LIMITED | MARKETED | 00808547 |
2 · Same class — other molecules in ATC M01AB
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Diclofenac | APO-DICLO · APO-DICLO RAPIDE 50 MG TABLETS · APO-DICLO SR · AVA-DICLOFENAC · +44 more | 74 | 15 | Yes |
| Ketorolac | APO-KETOROLAC · APO-KETOROLAC INJECTABLE · JAMP KETOROLAC · KETOROLAC TROMETHAMINE INJECTION USP · +12 more | 25 | 8 | Yes |
| Indometacin | APO-INDOMETHACIN · AURO-INDOMETHACIN · FTP-INDOMETHACIN · INDOCID CAP 25MG · +18 more | 31 | 7 | Yes |
| Diclofenac, Combinations | ACT DICLO-MISO · ARTHROTEC 50 · ARTHROTEC 75 · DICLOFENAC MISOPROSTOL · +4 more | 12 | 6 | Yes |
| Sulindac | APO-SULIN TAB 150MG · APO-SULIN TAB 200MG · CLINORIL TAB 150MG · CLINORIL TAB 200MG · +6 more | 12 | 2 | Yes |
| Etodolac | ETODOLAC · GEN-ETODOLAC 200MG · GEN-ETODOLAC 300MG · NOVO-ETODOLAC 200 MG · +5 more | 12 | 0 | Not in Canada |
| Tolmetin | NOVO-TOLMETIN CAPSULES 400MG · TOLECTIN 200 TAB 200MG · TOLECTIN 400 CAP 400MG · TOLECTIN TAB 600MG | 4 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC M01A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| M01AE | Fenoprofen · Flurbiprofen · Ibuprofen · Ibuprofen, Combinations · Ketoprofen · +5 more | 398 | 101 |
| M01AH | Celecoxib · Rofecoxib | 72 | 30 |
| M01AC | Meloxicam · Piroxicam · Tenoxicam | 67 | 14 |
| M01AG | Mefenamic Acid | 7 | 1 |
| M01AX | Nabumetone | 12 | 1 |
| M01AA | Oxyphenbutazone · Phenylbutazone · Phenylbutazone, Combinations | 7 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is SANDOZ DICLOFENAC RAPIDE called?
The same molecule, Diclofenac, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| CLOFENE | Latin | Morocco |
| VOLTARENE | Latin | Morocco |
| DIFAL | Latin | Morocco |
| XENID | Latin | Morocco |
| CATAFLAM | Latin | Morocco |
| DICLOBERL | Latin | Morocco |
| Diclofenac Sandoz | Latin | Australia |
| DICLOFENAC-WGR | Latin | Australia |
| DICLOMAX | Latin | Morocco |
| Fenac EC | Latin | Australia |
| Voltaren | Latin | South Africa |
| Voltaren Emulgel | Latin | South Africa |
| FENAC PROMOPHARM | Latin | Morocco |
| Panamor Gel | Latin | South Africa |
| PHARMAFLAM | Latin | Morocco |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.